RACGP CPD approvedEducational Activities
0.5 hrs
Reviewing Performance
0.5 hrs
Dr Kym Mina, Dr Saud Hamza and Dr Sanjana Kondola
Breast and ovarian cancer: who is eligible for genomic testing
Historically, cancer treatment was determined primarily by the organ of origin. Patients with breast cancer typically received uniform treatments, irrespective of the underlying biological drivers of their disease.
About the Authors
